Can't get no SMADisfaction: Smad proteins as positive and negative regulators of TGF-β family signals

BioEssays

Volumn 21, Issue 5, 1999, Pages 382-390

  Christian, Jan L ^a   Nakayama, Takuya ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; EMBRYO; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MORPHOGENESIS; PHYSIOLOGY; REVIEW; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; BODY PATTERNING; DNA-BINDING PROTEINS; EMBRYO; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 0033134805     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-1878(199905)21:5<382::AID-BIES5>3.0.CO;2-V     Document Type: Review

References (62)

1. Heldin C-H, Miyazono K, ten Dijke P. TGF-β signaling from cell membrane to nucleus through MAD proteins. Nature 1997;390:465-467.
2. Attisano L, Wrana JL. Mads and Smads in TGFβ signalling. Curr Opin Cell Biol 1998;10:188-194.
3. Kretzschmar M, Massagué J. SMADS: mediators and regulators of TGF-β signaling. Curr Opin Genet Dev 1998;8:103-111.
4. Padgett RW, Pradeep D, Krishna S. TGF-β signaling, Smads, and tumor suppressors. BioEssays 1998;20:382-390.
5. Whitman M. Smads and early developmental signaling by the TGFβ superfamily. Genes Dev 1998;12:2445-2462.
6. Yamashita H, ten Dijke P, Heldin C-H, Miyazono K. Bone morphogenetic protein receptors. Bone 1996;19:569-574.
7. Sekelsky JJ, Newfeld SJ, Raferty LA, Chartoff EH, Gelbart WM. Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 1995;139: 241-254.
8. Shi Y, Hata A, Lo RS, Massagué J, Pavletich NP. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 1997;388: 87-93.
9. Kawabata M, Inoue H, Hanya A, Imamura T, Miyazona K. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J 1998;17: 4056-4065.
10. Kretzschmar M, Liu F, Hata A, Doody J, Massagué J. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev 1997;11:984-995.
11. Nishimura R, Kato Y, Chen D, Harris SE, Mundy GR, Yoneda T. Smad5 and DPC4 are key molecules in mediating BMP-2 induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem 1998;273:1872-1879.
12. Tamaki K, Souchelnytsky S, Itoh S, Nakao A, Sampath K, Heldin C-H, ten Dijke P. Intracellular signaling of osteogenic protein-1 through Smad5 activation. J Cell Phys 1999;177:355-363.
13. Chen A, Bhushan A, Vale W. Smad5 mediates the signaling of the ALK-2 receptor serine kinase. Proc Natl Acad Sci USA 1997;94:12938-12943.
14. Maciás-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 1996;87: 1215-1224.
15. Zhang Y, Feng X-H, Wu RY, Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 1996;383:168-172.
16. 467 is required for Smad2-Smad4 complex formation and signaling. J Biol Chem 1997;272: 27678-27685.
17. 467 in the C-terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J Biol Chem 1997;272:28107-28115.
18. Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Lodish HF. Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells Proc Natl Acad Sci USA 1997;94:10669-10674.
19. Nakao A, Imamura T, Souchelnytsky S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai Jl, Heldin C-H, Miyazono K, ten Dijke P. TGF-β receptor-mediated signalling through Smad2, Smad5 and Smad4. EMBO J 1997;16:5353-5362.
20. Das P, Maduzia JL, Wang H, Finelli AL, Cho S-H, Smith MM, Padgett RW. The Drosophila gene Medea demonstrates the requirement for different classes of Smads in dpp signaling. Development 1998;125:1519-1528.
21. Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 1996;383:832-836.
22. Zhang Y, Musci T, Derynck R. The tumor suppressor Smad4/DPC4 as a central mediator of Smad function. Curr Biol 1997;7:270-276.
23. Zhou S, Buckhaults P, Zawel L, Bunz F, Riggins G, Dai JL, Kern SE, Kinzler KW, Vogelstein B. Targeted deletion of Smad4 shows it is required for transforming growth factor β and activin signaling in colorectal cancer cells. Proc Natl Acad Sci USA 1998;95:2412-2416.
24. Hudson JB, Podos SD, Keith K, Simpson SL, Ferguson EL. The Drosophila Medea gene is required downstream of dpp and encodes a functional homolog of human Smad4. Development 1998;125:1407-1420.
25. Wisotzkey RG, Mehra A, Sutherland DJ, Dobens LL, Liu X, Dohrmann C, Attisano L, Raftery LA. Medea is a Drosophila Smad4 homolog that is differentially required to potentiate DPP responses. Development 1998;125: 1433-1445.
26. Liu F, Hata A, Baker JC, Doody J, Caracamo J, Harland RM, Massagué J. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 1996;381:620-623.
27. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B, Kern SE. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1998;1:611-617.
28. Kim J, Johnson K, Chen HJ, Carroll S, Laughon A. Drosophila Mad binds DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 1997;388:304-308.
29. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier J-M. Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene, EMBO J 1998;17:3091-3100.
30. Eresh S, Riese J, Jackson DB, Bohman D, Bienz M. A CREB-binding site as a target for decapentaplegic signalling during Drosphila endoderm induction. EMBO J 1997;16:2014-2022.
31. Yingling J, Datto MB, Wong C, Frederick JP, Liberati NT, Wang X-F. Tumor suppressor Smad4 is a transforming growth factor β-inducibie DNA binding protein. Mol Cell Biol 1997;17:7019-7028.
32. Chen X, Rubock MJ, Whitman M. A transcriptional partner for MAD proteins in TGF-β signalling. Nature 1996;383:691-696.
33. Chen X, Weisberg E, Fridmacher V, Watanabe M, Naco G, Whitman M. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 1997;389:85-89.
34. Liu F, Pouponnot C, Massagué J. Dual role of the Smad4/DPC4 tumor suppressor in TGF-β-inducible transcriptional complexes. Genes Dev 1997;11:3157-3167.
35. Baker J, Harland R. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev 1996;10:1880-1889.
36. Meersseman G, Verschueren K, Nelles L, Blumenstock C, Kraft H, Wuytens G, Remade J, Kozak CA, Tylzanowski H, Niehrs C, Huylebroeck D. The C-terminal domain of Mad-like signal transducers is sufficient for biological activity in the Xenopus embryo and transcriptional activation. Mech Dev 1997;61:127-140.
37. Wu R-Y, Zhang Y, Feng X-H, Derynck R. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol Cell Biol 1997;17:2521-2528.
38. Hata A, Lo RS, Wotton D, Lagna G, Massagué J. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature 1997;388:82-87.
39. Topper JN, Cai J, Qui Y, Anderson KR, Xu X-Y, Deeds JD, Feeley R, Gimeno CJ, Woolf ES, Tayber O, Mays GG, Sampson BA, Schoen FJ, Gimbrone MA Jr, Falb D. Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc Natl Acad Sci USA 1997;94:9314-9319.
40. Tsuneizumi K, Nakayama T, Kamoshida Y, Kornberg TB, Christian JL, Tabata T. Daughters against dpp modulates dpp organizing activity in Drosophila wing development. Nature 1997;389:627-630.
41. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J-I, Kawabata M, Miyazono K, Smad6 inhibits signalling by the TGF-β superfamily. Nature 1997;389:622-626.
42. Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Heldin N, Heldin C, ten Dijke P. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature 1997;39:631-635.
43. Nakayama T, Snyder MA, Grewal SS, Tsuneizumi K, Tabata T, Christian JL. Smad8 acts downstream of BMP-4 to modulate its activity during vertebrate embryonic patterning. Development 1998;125:857-867.
44. Nakayama T, Gardner H, Berg LK, Christian JL. Smad6 functions as an intracellular antagonist of some TGF-β family members during Xenopus embryogenesis. Genes Cells 1998;3:387-394.
45. Hata A, Lagna G, Massagué J, Hemmati-Brivanlou A. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 1998;12:186-197.
46. Souchelnytskyi S, Nakayama T, Nakao A, Morén A, Heldin C-H, Christian JL, ten Dijke P. Physical and functional interaction of murine and Xenopus Smad7 with BMP and TGF-β receptors. J Biol Chem 1998;273:25364-25370.
47. Inoue H, Imamura T, Ishidou Y, Takase M, Udagawa Y, Oka Y, Tsuneizumi K, Tabata T, Miyazono K, Kawabata M. Interplay of signal mediators of decapentaplegic (dpp): molecular characterization of mothers against dpp, Medea, and daughters against dpp. Mol Bio Cell 1998;9:2145-2156.
48. Bhushan A, Chen Y, Vale W. Smad7 inhibits mesoderm formation and promotes neural cell fate in Xenopus embryos Dev Biol 1998;200: 260-268.
49. Casellas R, Brivanlou AH. Xenopus Smad7 inhibits both the activin and BMP pathways and acts as a neural inducer. Dev Biol 1998;198:1-12.
50. Hayashi H, Abdollah S, Qui Y, Cai J, Xu Y-Y, Grinnell BW, Richardson MA, Topper JN, Gimbrone JMA, Wrana JL, Falb D. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 1997;89:1165-1173.
51. Candia AF, Watabe T, Hawley SHB, Onichtchouk D, Zhang Y, Derynck R, Niehrs C, Cho KWY. Cellular interpretation of multiple TGF-β signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. Development 1997;124:4467-4480.
52. Takase M, Imamura T, Sampath TK, Takeda K, Ichijo H, Miyazono K, Kawabata M. Induction of Smad6 mRNA by bone morphogenetic proteins. Biochem Biophys Res Commun 1998;244:26-29.
53. Perrimon N, Perkins LA. There must be 50 ways to rule the signal: the case of the Drosophila EGF receptor. Cell 1997;89:13-16.
54. Hammerschmidt M, Brook A, McMahon AP. The world according to hedgehog. Trends Genet 1997;13:14-21.
55. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997;387: 921-924.
56. Naka T, Narazaki M, Hirata M, Matsumotot T, Minamoto S, Aono A, Nishimotot N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997;387: 924-929.
57. Starr R, Willson TA, Viney EM, Murray LJL, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ. A family of cytokine-inducible inhibitors of signalling. Nature 1997;387:917-921.
58. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K. Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 1995;270: 2008-2011.
59. Shibuya H, Iwata H, Masuyama N, Gotoh Y, Yamaguchi K, Irie K, Matsumoto K, Nishida E, Ueno N. Role of TAK1 and TAB1 in BMP signaling in early Xenopus development. EMBO J 1998;17:1019-1028.
60. Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbausm HA, Ruvkun G. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 1997;389: 994-999.
61. Kretzschmar M, Doody J, Massagué J. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature 1997;389:618-622.
62. Zimmerman CM, Kariapper MST, Mathew L. Smad proteins physically interact with calmodulin. J Biol Chem 1998;273:677-680.